{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:56:15Z","timestamp":1791860175378,"version":"4.3.4"},"reference-count":29,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,6,1]]},"DOI":"10.1210\/jc.2006-2865","type":"journal-article","created":{"date-parts":[[2007,3,20]],"date-time":"2007-03-20T20:20:30Z","timestamp":1174422030000},"page":"2374-2377","source":"Crossref","is-referenced-by-count":130,"title":["Determination of the Elimination Half-Life of Fibroblast Growth Factor-23"],"prefix":"10.1210","volume":"92","author":[{"given":"Azarmindokht","family":"Khosravi","sequence":"first","affiliation":[{"name":"Skeletal Clinical Studies Unit (A.K., C.M.C., M.H.K., M.T.C.), Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolee M.","family":"Cutler","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (A.K., C.M.C., M.H.K., M.T.C.), Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn H.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (A.K., C.M.C., M.H.K., M.T.C.), Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Radiology (R.C.), Mark O. Hatfield Clinical Center, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E.","family":"Royal","sequence":"additional","affiliation":[{"name":"Surgery Branch (R.E.R., R.M.S.), National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M.","family":"Sherry","sequence":"additional","affiliation":[{"name":"Surgery Branch (R.E.R., R.M.S.), National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felasfa M.","family":"Wodajo","sequence":"additional","affiliation":[{"name":"Department of Orthopedics and Pediatrics (F.M.W.), Georgetown University, Washington, D.C."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal S.","family":"Fedarko","sequence":"additional","affiliation":[{"name":"Division of Geriatric Medicine and Gerontology (N.S.F.), Department of Medicine, Johns Hopkins University, Baltimore, Maryland 21224"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T.","family":"Collins","sequence":"additional","affiliation":[{"name":"Skeletal Clinical Studies Unit (A.K., C.M.C., M.H.K., M.T.C.), Craniofacial and Skeletal Diseases Branch, National Institute of Dental and Craniofacial Research, Bethesda, Maryland 20892"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"key\n\t\t\t\t2019041113574922500_R1","first-page":"1645","article-title":"Brief report: inhibition of renal phosphate transport by a tumor product in a patient with oncogenic osteomalacia.","volume":"330","author":"Cai","year":"1994","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113574922500_R2","first-page":"1502","article-title":"Tumor-induced osteomalacia: clinical and basic studies.","volume":"12","author":"Shane","year":"1997","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113574922500_R3","first-page":"1260","article-title":"Tumor-induced osteomalacia.","volume":"294","author":"Jan de Beur","year":"2005","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019041113574922500_R4","first-page":"333","article-title":"Tumor-induced osteomalacia and the regulation of phosphate homeostasis.","volume":"27","author":"Kumar","year":"2000","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113574922500_R5","first-page":"175","article-title":"Tumor-induced osteomalacia.","volume":"2","author":"Drezner","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"key":"key\n\t\t\t\t2019041113574922500_R6","first-page":"1","article-title":"Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature.","volume":"28","author":"Folpe","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"key\n\t\t\t\t2019041113574922500_R7","first-page":"497","article-title":"The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting.","volume":"86","author":"White","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113574922500_R8","first-page":"1656","article-title":"Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia.","volume":"348","author":"Jonsson","year":"2003","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t2019041113574922500_R9","first-page":"4957","article-title":"Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia.","volume":"87","author":"Yamazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113574922500_R10","first-page":"683","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting.","volume":"112","author":"Riminucci","year":"2003","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113574922500_R11","first-page":"1192","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"key\n\t\t\t\t2019041113574922500_R12","first-page":"421","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice.","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol"},{"key":"key\n\t\t\t\t2019041113574922500_R13","first-page":"2161","article-title":"Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals.","volume":"169","author":"Sitara","year":"2006","journal-title":"Am J Pathol"},{"key":"key\n\t\t\t\t2019041113574922500_R14","first-page":"6500","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia.","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t2019041113574922500_R15","first-page":"2206","article-title":"Human fibroblast growth factor-23 mutants suppress Na+-dependent phosphate co-transport activity and 1\u03b1,25-dihydroxyvitamin D3 production.","volume":"278","author":"Saito","year":"2003","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113574922500_R16","first-page":"5269","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders.","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"key\n\t\t\t\t2019041113574922500_R17","first-page":"2543","article-title":"Circulating FGF-23 is regulated by 1\u03b1,25-dihydroxyvitamin D3 and phosphorus in vivo.","volume":"280","author":"Saito","year":"2005","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113574922500_R18","first-page":"429","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis.","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113574922500_R19","first-page":"561","article-title":"Targeted ablation of Ffg23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism.","volume":"113","author":"Shimada","year":"2004","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t2019041113574922500_R20","first-page":"2205","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease.","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"key\n\t\t\t\t2019041113574922500_R21","first-page":"1944","article-title":"Fibroblast growth factor-23 is regulated by 1\u03b1,25-dihydroxyvitamin D.","volume":"20","author":"Collins","year":"2005","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113574922500_R22","first-page":"3979","article-title":"Venous sampling for fibroblast growth factor-23 confirms preoperative diagnosis of tumor-induced osteomalacia.","volume":"89","author":"Takeuchi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113574922500_R23","first-page":"15","article-title":"The assessment of phosphate reabsorption.","volume":"26","author":"Bijvoet","year":"1969","journal-title":"Clin Chim Acta"},{"key":"key\n\t\t\t\t2019041113574922500_R24","first-page":"3852","article-title":"Parathyroid hormone after adenectomy for primary hyperparathyroidism. A study of peptide hormone elimination kinetics in humans.","volume":"83","author":"Maier","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t2019041113574922500_R25","first-page":"579","article-title":"Mutations in GALNT3, encoding a protein involved in O-linked glycosylation, cause familial tumoral calcinosis.","volume":"36","author":"Topaz","year":"2004","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t2019041113574922500_R26","first-page":"412","article-title":"Protein glycosylation in development and disease.","volume":"21","author":"Dennis","year":"1999","journal-title":"Bioessays"},{"key":"key\n\t\t\t\t2019041113574922500_R27","first-page":"18370","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation.","volume":"281","author":"Kato","year":"2006","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t2019041113574922500_R28","first-page":"1102","article-title":"Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism.","volume":"17","author":"De Beur","year":"2002","journal-title":"J Bone Miner Res"},{"key":"key\n\t\t\t\t2019041113574922500_R29","first-page":"1486","article-title":"Post-transplant hypophosphatemia: tertiary \u2018hyper-phosphatoninism\u2019?","volume":"70","author":"Bhan","year":"2006","journal-title":"Kidney Int"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/92\/6\/2374\/10780658\/jcem2374.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T00:46:14Z","timestamp":1555029974000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/92\/6\/2374\/2598190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,6,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2006-2865","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,1]]}}}